Bilibili Inc. BLBLF OTC · Communication services · China
$15.13 +0.00% +$0.00
Summary
47 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Revenue grew by 11% a year over the last 3 years.
- Analysts expect revenue to grow by 11% this fiscal year.
What to watch
- It earns only 5.2 CNY a year on every 100 CNY of invested capital.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 27.7 CNY for 1 CNY of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (CNY)
Diluted EPS (CNY)
- Analyst estimate
Revenue grew by 20% a year over 5 years. Over the last 3 years it grew by 11% a year. For the next fiscal year analysts expect revenue to grow by 11%.
Growth in detailDoes it make money?
PoorlyWhere 100 CNY of revenue goes
- Cost of sales 63 CNY
- Research and development 12 CNY
- Sales and administration 21 CNY
- Taxes and other -0.4 CNY
- Net profit 4.9 CNY
Net profit, industry median (Internet Content & Information) 16 CNY
Out of every 100 CNY of revenue, 4.9 CNY is left as net profit.
Profitability in detailIs it financially healthy?
YesIt holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 8
- Hold 8
- Sell 0
No analyst has published a price target.
50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Value Added Services 42%
- Advertising 35%
- Mobile Game Services 23%
By region
The company reports no revenue by region.
Value Added Services brings in 42% of revenue.
Segments in detail